Department of Molecular Oncology, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
IDAC Fellow Laboratory, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
Oncogene. 2022 May;41(19):2706-2718. doi: 10.1038/s41388-022-02299-6. Epub 2022 Apr 7.
DNA double-strand break (DSB) repair-pathway choice regulated by 53BP1 and BRCA1 contributes to genome stability. 53BP1 cooperates with the REV7-Shieldin complex and inhibits DNA end resection to block homologous recombination (HR) and affects the sensitivity to inhibitors for poly (ADP-ribose) polymerases (PARPs) in BRCA1-deficient cells. Here, we show that a REV7 binding protein, CHAMP1 (chromosome alignment-maintaining phosphoprotein 1), has an opposite function of REV7 in DSB repair and promotes HR through DNA end resection together with POGZ (POGO transposable element with ZNF domain). CHAMP1 was recruited to laser-micro-irradiation-induced DSB sites and promotes HR, but not NHEJ. CHAMP1 depletion suppressed the recruitment of BRCA1, but not the recruitment of 53BP1, suggesting that CHAMP1 regulates DSB repair pathway in favor of HR. Depletion of either CHAMP1 or POGZ impaired the recruitment of phosphorylated RPA2 and CtIP (CtBP-interacting protein) at DSB sites, implying that CHAMP1, in complex with POGZ, promotes DNA end resection for HR. Furthermore, loss of CHAMP1 and POGZ restored the sensitivity to a PARP inhibitor in cells depleted of 53BP1 together with BRCA1. These data suggest that CHAMP1and POGZ counteract the inhibitory effect of 53BP1 on HR by promoting DNA end resection and affect the resistance to PARP inhibitors.
DNA 双链断裂 (DSB) 修复途径的选择受 53BP1 和 BRCA1 调控,有助于基因组稳定性。53BP1 与 REV7-Shieldin 复合物合作,抑制 DNA 末端切除,阻断同源重组 (HR),并影响 BRCA1 缺陷细胞中聚 (ADP-核糖) 聚合酶 (PARPs) 抑制剂的敏感性。在这里,我们表明,REV7 结合蛋白 CHAMP1(染色体对齐维持磷酸化蛋白 1)在 DSB 修复中具有与 REV7 相反的功能,通过与 POGZ(具有 ZNF 结构域的 POG 转座元件)一起促进 DNA 末端切除,从而促进 HR。CHAMP1 被招募到激光微照射诱导的 DSB 位点,并促进 HR,而不是 NHEJ。CHAMP1 耗竭抑制了 BRCA1 的募集,但不抑制 53BP1 的募集,表明 CHAMP1 调节 DSB 修复途径有利于 HR。CHAMP1 或 POGZ 的耗竭均损害了 DSB 位点磷酸化 RPA2 和 CtIP(CtBP 相互作用蛋白)的募集,表明 CHAMP1 与 POGZ 形成复合物,促进 HR 的 DNA 末端切除。此外,CHAMP1 和 POGZ 的缺失恢复了 53BP1 和 BRCA1 耗竭细胞对 PARP 抑制剂的敏感性。这些数据表明,CHAMP1 和 POGZ 通过促进 DNA 末端切除来抵消 53BP1 对 HR 的抑制作用,并影响对 PARP 抑制剂的耐药性。